Related Experiment Videos
Diabetes and atherosclerosis--a lipoprotein perspective
1Department of Medicine at The University of Toronto and The Toronto Hospital, and The World Health Organization Collaborating Centre for the Study of Atherosclerosis in Diabetes, Canada.
Summary
Diabetes complications include atherosclerosis, affecting major blood vessels. Research is exploring if managing abnormal blood lipid metabolism in diabetics can lower this risk.
Area of Science:
- Cardiovascular Medicine
- Metabolic Disorders
- Endocrinology
Background:
- Atherosclerosis is a primary complication of diabetes mellitus.
- Diabetes impacts all major vascular beds, contributing to significant morbidity.
- Metabolic abnormalities in diabetes, especially lipoprotein metabolism, are key factors.
Purpose of the Study:
- To investigate the link between diabetes-associated metabolic derangements and atherosclerosis.
- To determine if correcting dyslipoproteinaemias reduces atherosclerosis risk in diabetic patients.
Main Methods:
- Observational studies analyzing metabolic profiles in diabetic populations.
- Clinical trials assessing interventions for dyslipoproteinaemia in diabetes.
- Vascular imaging and risk factor analysis.
Main Results:
- Diabetic dyslipoproteinaemia, particularly involving triglyceride-rich lipoproteins, is strongly associated with atherosclerosis.
- Ongoing studies aim to validate the therapeutic benefit of lipid management.
Conclusions:
- Metabolic derangements in diabetes significantly contribute to atherosclerosis.
- Targeting dyslipoproteinaemias may be a crucial strategy for preventing vascular complications in diabetes.